Agonist stimulation of the 5-HT1A receptor causes sustained MAPK activation, caspase inhibition and neuroprotection

被引：0
|
作者：
Adayev, T
El-Sherif, Y
Barua, M
Penington, N
Banerjee, P
机构：
[1] CUNY, CDN, Staten Isl, NY USA
[2] CUNY, Dept Chem, Staten Isl, NY USA
[3] SUNY Hlth Sci Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA
来源：
JOURNAL OF NEUROCHEMISTRY | 1999年 / 72卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [1] Effect of the stimulation of serotonin1A (5-HT1A) receptor on neurogenesis and neuroprotection
    Kuzumaki, ONaoko
    Narita, Minoru
    Suzuki, Tsutomu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 116 - 116
  • [2] The functional change in the 5-HT1A receptor induced by stress and the role of the 5-HT1A receptor in neuroprotection
    Miyagawa, K
    Narita, M
    Miyatake, M
    Suzuki, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 128P - 128P
  • [3] Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission
    Haddjeri, N
    Ortemann, C
    de Montigny, C
    Blier, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (05) : 427 - 440
  • [4] Electrophysiological evidence for rapid 5-HT1A autoreceptor inhibition by vilazodone, a 5-HT1A receptor partial agonist and 5-HT reuptake inhibitor
    Ashby, Charles R., Jr.
    Kehne, John H.
    Bartoszyk, Gerd D.
    Renda, Matthew J.
    Athanasiou, Maria
    Pierz, Kerri A.
    Seyfried, Christoph A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 714 (1-3) : 359 - 365
  • [5] Occupancy of Agonist Drugs at the 5-HT1A Receptor
    R Alexander Bantick
    Eugenii A Rabiner
    Ella Hirani
    Michiel H de Vries
    Susan P Hume
    Paul M Grasby
    Neuropsychopharmacology, 2004, 29 : 847 - 859
  • [6] Occupancy of agonist drugs at the 5-HT1A receptor
    Bantick, RA
    Rabiner, EA
    Hirani, E
    de Vries, MH
    Hume, SP
    Grasby, PM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 847 - 859
  • [7] Regulation of agonist efficacy at the 5-HT1A receptor
    McLoughlin, DJ
    Evans, KJ
    Clarke, WP
    FASEB JOURNAL, 2001, 15 (04): : A219 - A219
  • [8] Novel antipsychotic agents with 5-HT1A agonist properties:: Role of 5-HT1A receptor activation in attenuation of catalepsy induction in rats
    Kleven, MS
    Barret-Grévoz, C
    Slot, LB
    Newman-Tancredi, A
    NEUROPHARMACOLOGY, 2005, 49 (02) : 135 - 143
  • [9] Efficacy of a 5-HT1a receptor agonist in atopic dermatitis
    Kawana, S.
    Kato, Y.
    Omi, T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (08) : 835 - 840
  • [10] The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Cα
    Adayev, T
    Ray, T
    Sondhi, R
    Sobocki, T
    Banerjee, P
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1640 (01): : 85 - 96
12345